This content is only available within our institutional offering.
31 Oct 2023
Q323 results and 15 questions for management
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Q323 results and 15 questions for management
- Published:
31 Oct 2023 -
Author:
Stent Jeff JS | Cross Gen GC | Ford Matthew MF -
Pages:
17 -
Summary of Q323 results
EBITDA at USD5,431m was +2.1% ahead of co. cons. and EBIT at USD4,027m was +0.8% ahead of co. cons. As to the LFL development, we note that ABInBev reported +5.0% LFL sales growth reflecting a -3.4% volume decline and +9.0% rev/hl growth. Excluding Argentina, Q3 LFL sales would have grown by +1.6%. LFL EBITDA grew by +4.1%. Basic underlying EPS at USD0.86 was +1.6% ahead of co. cons.
News
We highlight that ABInBev commented that its value share losses in the US are showing some signs of recovery.
Earnings
We make relatively modest adjustments to our earnings estimates.
Investment thesis
We believe that the market will slowly come to positively view ABInBev as a large cash return generator.
Rating and target price
We maintain our Outperform rating and EUR64 target price.
15 questions for management
Argentina is materially distorting the LFL performance of the group, why not embrace the price-capping practice that is embraced by most of your European staples'' peers?